Safety and efficacy of retromuscular-onlay dual-mesh reconstruction for massive abdominal wall defects secondary to abdominal wall endometriosis resection - Scorecard - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Evaluation of the Safety and Effectiveness of Retromuscular-Onlay Dual-Mesh Repair for Significant Abdominal Wall Defects Following Resection of Abdominal Wall Endometriosis

  • By

  • Dongbing Ding

  • Yuan Wang

  • Han Wang

  • Rongpu Liang

  • Jiarong You

  • Qingjian Ye

  • Bo Wei

  • May 13, 2026

Share

Clinical Scorecard: Evaluation of the Safety and Effectiveness of Retromuscular-Onlay Dual-Mesh Repair for Significant Abdominal Wall Defects Following Resection of Abdominal Wall Endometriosis

At a Glance

CategoryDetail
Condition
Key Mechanisms
Target PopulationFemale patients aged 18-50 with significant abdominal wall defects post-AWE resection.
Care Setting

Key Highlights

  • average_length_of_stay

Guideline-Based Recommendations

Diagnosis

  • Histologically confirm AWE through preoperative assessment including symptoms, physical examination, and imaging (e.g., ultrasound, MRI).

Management

    Monitoring & Follow-up

      Risks

        Patient & Prescribing Data

        Standardized dual-mesh approach is safe and effective for reconstructing abdominal wall defects, with potential for reduced recurrence rates.

        Clinical Best Practices

        • Utilize component separation technique (CST) for optimal anatomical restoration, supported by recent studies.

        Related Resources & Content

        Original Source(s)

        Safety and efficacy of retromuscular-onlay dual-mesh reconstruction for massive abdominal wall defects secondary to abdominal wall endometriosis resection

        • by Dongbing Ding, Yuan Wang, Han Wang, Rongpu Liang, Jiarong You, Qingjian Ye, Bo Wei

        • May 13, 2026

        Related Content

        What happens to clinical skills when AI does the routine work?

        “The need to be extra vigilant when you're reviewing something versus doing it from scratch can be a real problem.”

        Continuous Monitoring Boosts Liver Assessment

        A new biochemical sensor could provide a more complete picture of donor liver health

        • August 28, 2026

        • 2 min
        FDA monthly preview: Key September decisions to watch

        Several FDA decisions across multiple specialties are expected this month.